Zydus Lifesciences

BSE : 532321 | NSE : ZYDUSLIFE

Industry : Pharmaceuticals | ISIN : INE010B01027 | FreeFloat : 30.00% | FnO : Yes | LotSize : 1100


Intellectual Capital (IC)24,645.86
Net Worth (NW)18,824.44
Intrinsic Worth (IW)43,470.30
Market Cap (MC)49,462.12
Economic Value Added-108.66
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)56.70%
IC Gross Margin (EBITDA/IC)14.65%
IC Net Margin (NPT/IC)9.73%
Knowledge Turnover (Sales/IC)0.63
Market to Intrinsic Value (MC/IW)1.14

As OfIntrinsic ValueMarket Price
31 Dec 2021Rs. 424.62Rs. 483.15
18 May 2022 ---- Rs. 347.40
-1.65     -0.47%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 339.23ReduceSell
KB > 50% : Yes50 DMA : Rs. 355.13
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-19
C
3732.80
3771.20
838.80
683.20
605.90
479.20
509.60
Jun-19
C
3496.30
3518.90
654.60
483.00
393.90
303.60
360.30
Sep-19
C
3366.60
3393.50
384.40
212.10
122.40
107.20
-7.00
Dec-19
C
3638.10
3658.20
711.70
537.60
457.10
373.90
356.70
Mar-20
C
3752.10
3796.40
783.00
604.50
522.00
391.90
193.90
Jun-20
C
3639.90
3662.40
837.90
661.10
593.40
454.00
463.80
Sep-20
C
3820.00
3847.50
758.90
579.90
534.20
473.40
554.70
Dec-20
C
3795.60
3823.10
834.40
654.00
627.20
527.20
543.70
Mar-21
C
3846.70
3806.40
741.90
553.30
530.00
679.00
673.90
Jun-21
C
4025.40
4057.00
964.60
781.90
754.60
587.20
536.10
Sep-21
C
3784.80
3838.10
914.10
729.30
699.20
515.80
506.20
Dec-21
C
3655.00
3715.80
813.30
630.10
599.00
500.40
513.80
* C - Consolidated, S - Standalone